Skip to main content

Table 2 Dopamine transporter availability between subgroups of PD patients and healthy controls, respectively

From: Current coffee consumption is associated with decreased striatal dopamine transporter availability in Parkinson’s disease patients and healthy controls

 

PD-CC (n = 88)

PD-FC (n = 18)

PD-NC (n = 32)

p values

HC-CC (n = 55)

HC-FC (n = 9)

HC-NC (n = 11)

p values

Caudate

1.95 ± 0.48

2.28 ± 0.63

2.19 ± 0.41

0.008**

2.99 ± 0.59

3.52 ± 0.69

3.34 ± 0.80

0.031*

Putamen

0.79 ± 0.27

0.84 ± 0.27

0.87 ± 0.22

0.317

2.17 ± 0.55

2.34 ± 0.51

2.59 ± 0.72

0.075

  1. Bold values indicate significant differences
  2. PD-CC current consumers of Parkinson’s disease, PD-FC former consumers of Parkinson’s Disease, PD-NC never consumers of Parkinson’s Disease, HC-CC current consumers of healthy controls, HC-FC former consumers of healthy controls, HC-NC never consumers of healthy controls
  3. *Bonferroni uncorrected (p < 0.05)
  4. **Bonferroni corrected (p < 0.05/4 = 0.0125)
Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us